Marburg, Germany

Holger Lind

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Holger Lind: Innovator in Recombinant Factor Production

Introduction

Holger Lind is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant von Willebrand factor. With a total of 4 patents to his name, Lind's work has advanced the methods used in biopharmaceutical production.

Latest Patents

Lind's latest patents include innovative methods for the production and concentration of von Willebrand factor. One of his key inventions is the "Production of recombinant von Willebrand factor in a bioreactor," which focuses on improved methods for producing vWF by separating different multimeric forms during fermentation. Another significant patent is the "Method to concentrate von Willebrand factor or complexes thereof," which describes a process for concentrating vWF from an aqueous solution using calcium and phosphate ions.

Career Highlights

Throughout his career, Holger Lind has worked with prominent companies in the biotechnology sector. He has been associated with CSL Behring GmbH and CSL Limited, where he has contributed to the development of biopharmaceutical products. His expertise in recombinant protein production has positioned him as a valuable asset in the industry.

Collaborations

Lind has collaborated with several professionals in his field, including Thomas Weimer and Stefan Schulte. These collaborations have further enhanced his research and development efforts in biotechnology.

Conclusion

Holger Lind's innovative work in the production of recombinant von Willebrand factor has made a significant impact in the biotechnology industry. His patents and collaborations reflect his commitment to advancing biopharmaceutical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…